EVX-020

N/A

Report date: 2024/01/10 17:54:46

Base Information

Drug NameEVX-020
Drug Alias NameEVX-020DIACC-2020
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionKinesin-like protein KIF20A inhibitors
TargetsKinesin-like protein KIF20A
Therapy Area/IndicationsSolid tumoursHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEvexta Bio SA
China Registration ClassN/A

Develop Information

Active CompaniesEvexta Bio SA
Inactive CompaniesN/A
Active IndicationsSolid tumoursHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A